Pentokey Organy (India) Limited is a Mumbai-based public limited company currently undergoing a significant strategic pivot. Historically a specialized trader in the pharmaceutical sector, the company is aggressively diversifying its operational footprint to become a multi-category player in the **Agrochemical, Industrial Chemical, and Petrochemical** sectors. The company operates under **Indian Accounting Standards (Ind AS)** and maintains a lean, asset-light operational model. --- ### **Strategic Pivot: From Pharma Trading to Chemical Diversification** The company is transitioning from a **single-segment** pharmaceutical trading entity into a diversified manufacturer and trader of a broad spectrum of chemical products. This shift was formalized through an amendment to the **Memorandum of Association (MoA)** in **June 2025**. **New Target Segments & Product Categories:** * **Agrochemicals:** Trading and manufacturing of **insecticides, fertilizers, pesticides, weedicides, fungicides, and rodenticides**. * **Industrial & Specialty Chemicals:** Expansion into **petrochemicals, acids, alkalies, salts, fumigants, graphite, and carbon**. * **Operational Evolution:** Moving from purely **Organic Chemicals** (Bulk drugs and formulations) into **Inorganic Chemicals** to capture emerging industrial demand. --- ### **Financial Performance & Revenue Trajectory** The company’s financial profile has shown significant volatility as it scales and shifts its business focus. While **FY 2022-23** saw peak revenues, the most recent fiscal year indicates a contraction in the top line as the company prepares for its new diversified segments. | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Revenue from Operations** | **₹1.29 Crore** | **₹4.85 Crore** | **₹6.72 Crore** | | **Profit After Tax (PAT)** | **₹24.55 Lakh** | *Not Specified* | **₹3.18 Crore** | | **Domestic Sales** | **₹82.62 Lakh** | **₹372.92 Lakh** | **₹436.55 Lakh** | | **Export Sales** | **₹0.00** | **₹66.71 Lakh** | **₹0.00** | *Note: Revenue figures for FY 2024-25 reflect a transitional period. The company reported **₹82.62 Lakh** in core trading revenue, with total income reaching **₹1.29 Crore**.* --- ### **Capital Structure and Liquidity Management** Pentokey Organy maintains a conservative financial structure with a focus on internal resource conservation. * **Equity Capital:** As of March 31, 2025, the **Paid-up Equity Share Capital** is **₹6,27,26,290**, consisting of **62,72,629 equity shares** (Face Value **₹10**). * **Dividend Policy:** The company has **not recommended dividends** for the last three fiscal years, opting to retain earnings to fund its diversification strategy. * **Debt & Gearing:** The company maintains a strict policy to cap its **gearing ratio** (net debt to total capital) at **40%**. Currently, it reports **NIL** exposure to interest rate risk. * **Public Deposits:** The company has **not accepted any public deposits** under Section 73 of the Companies Act, 2013. * **Subsidiaries:** The entity operates independently with **no subsidiaries or associate companies**. --- ### **Operational Infrastructure & Human Capital** The company utilizes a highly streamlined operational model to minimize overhead during its transition phase. * **Headcount:** As of March 31, 2025, the company employs only **3 permanent employees**. * **Leadership:** In **August 2023**, the leadership was consolidated, with **Mr. Rajendra Gujarathi (CEO)** assuming the additional responsibilities of **Chief Financial Officer (CFO)**. * **Asset Base:** The company holds **no Property, Plant, and Equipment (PPE) outside of India**. * **Employee Benefits:** There is currently **no liability for Gratuity or Leave Encashment** recorded in the latest reporting period. --- ### **Risk Profile & Contingent Liabilities** Investors should note several legacy legal and tax issues that remain unresolved, alongside standard market risks. #### **1. Legal and Tax Contingencies** | Issue | Period | Status / Financial Impact | | :--- | :--- | :--- | | **Income Tax Demand** | **AY 2015-16** | Demand of **₹1.72 Crore** following a re-assessment. Appeal filed with **ITAT, Mumbai** on **April 17, 2025**. | | **Labour Complaints** | **2006-2007** | Alleged non-payment of dues during a "sick" period. Pending before **Judicial Magistrate, Khed**; penalties are currently **unquantifiable**. | | **MSEDCL Dispute** | Pre-**2017** | Dispute over electricity deposits. **₹51.54 Lakh** written off; Writ pending at **Bombay High Court**. | #### **2. Financial & Market Risks** * **Liquidity Risk:** Management reports **no liquidity risk**, as current assets are sufficient to cover all maturing financial liabilities. * **Foreign Currency Risk:** Minimal exposure; trade payables for imports stood at **₹7.69 Lakh** as of March 2025. * **Credit & Inventory Risk:** Trade receivables were **₹14.56 Lakh** (March 2023), managed via a "simplified approach" for expected credit losses. Stock-in-trade was valued at **₹20.57 Lakh**, subject to price volatility. * **Regulatory Risk:** Expansion into fertilizers and pesticides requires strict adherence to **Section 102 of the Companies Act, 2013** and specific agrochemical licenses. --- ### **Internal Controls and Governance** The company has implemented statutory-aligned internal control systems to mitigate operational risks: * **Automated Reporting:** Utilization of **auto-generated MIS reports** to reduce human error and ensure data integrity. * **Audit Quality:** Financial statements have consistently received **unmodified Limited Review reports** from statutory auditors, indicating no major accounting discrepancies. * **Going Concern:** No orders have been passed by regulators or courts that threaten the company’s status as a **going concern**.